These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29880269)

  • 1. Barrett's esophagus: A comprehensive review for the internist.
    Klavan H; Russell MB; Macklin J; Lee E; Aslanian HR; Muniraj T
    Dis Mon; 2018 Nov; 64(11):471-487. PubMed ID: 29880269
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
    DE Carli DM; Araujo AF; Fagundes RB
    Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Columnar-celled metaplasia and adenocarcinoma of the esophagus in inhabitants of the Leningrad oblast (by the data of esophagogastroduodenoscopy)].
    Vasilevskiĭ DI; Silant'ev DS; Mikhaleva KV; Priadko AS; Filin AV; Vorob'ev SL; Mednikov SN; Luft AV; Kulagin VI; Bagnenko SF
    Vestn Khir Im I I Grek; 2012; 171(6):76-9. PubMed ID: 23488270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and prevention of oesophageal adenocarcinoma.
    Ness-Jensen E
    Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of Barrett's esophagus.
    Milind R; Attwood SE
    World J Gastroenterol; 2012 Jul; 18(27):3483-91. PubMed ID: 22826612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and treatment of Barrett's esophagus.
    Oh DS; Demeester SR
    World J Gastroenterol; 2010 Aug; 16(30):3762-72. PubMed ID: 20698038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medical and surgical treatment of Barrett's metaplasia.
    Wassenaar EB; Oelschlager BK
    World J Gastroenterol; 2010 Aug; 16(30):3773-9. PubMed ID: 20698039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors for Barrett's oesophagus.
    Triadafilopoulos G
    Gut; 2000 Feb; 46(2):144-6. PubMed ID: 10644301
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: gastroesophageal reflux disease Anno 2010.
    Tytgat G
    J Dig Dis; 2010 Apr; 11(2):67-71. PubMed ID: 20402830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathologic anatomy of Barrett's esophagus].
    Zaĭrat'iants OV; Maev IV; Smol'iannikova VA; Movtaeva PR
    Arkh Patol; 2011; 73(3):21-6. PubMed ID: 21853919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment.
    Clark GW; Ireland AP; DeMeester TR
    Dig Dis; 1996; 14(4):213-27. PubMed ID: 8843978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.